DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of BioScrip, Inc. of Upcoming Deadline
15 Novembre 2013 - 4:51PM
Business Wire
Rigrodsky & Long, P.A.:
- Do you, or did you, own shares of
BioScrip, Inc. (NASDAQ GS: BIOS)?
- Did you purchase your shares before
August 8, 2011, or between August 8, 2011 and September 20, 2013,
inclusive?
- Did you lose money in your
investment in BioScrip, Inc.?
- Do you want to discuss your
rights?
Rigrodsky & Long, P.A., including former Special Assistant
United States Attorney, Timothy J. MacFall, reminds shareholders of
BioScrip, Inc. (“BioScrip” or the “Company”) (NASDAQ GS: BIOS) of
an upcoming deadline involving a securities fraud class action
lawsuit commenced against the Company.
A complaint was filed in the United States District Court for
the Southern District of New York on behalf of all persons or
entities that purchased the common stock of BioScrip, between
August 8, 2011 and September 20, 2013, inclusive (the “Class
Period”), alleging violations of the Securities Exchange Act of
1934 against the Company and certain of its officers (the
“Complaint”). If you wish to serve as lead plaintiff, you must move
the Court no later than November 29, 2013.
If you purchased shares of BioScrip during the Class Period, or
purchased shares prior to the Class Period and still hold BioScrip,
and wish to discuss this action or have any questions concerning
this notice or your rights or interests, please contact Timothy J.
MacFall, Esquire or Peter Allocco of Rigrodsky & Long, P.A.,
825 East Gate Boulevard, Suite 300, Garden City, NY at (888)
969-4242, by e-mail to info@rl-legal.com, or at:
http://www.rigrodskylong.com/investigations/bioscrip-inc-bios.
A lead plaintiff is a representative party acting on behalf of
other class members in directing the litigation. In order to be
appointed lead plaintiff, the Court must determine that the class
member’s claim is typical of the claims of other class members, and
that the class member will adequately represent the class. Your
ability to share in any recovery is not, however, affected by the
decision whether or not to serve as a lead plaintiff. Any member of
the proposed class may move the court to serve as lead plaintiff
through counsel of their choice, or may choose to do nothing and
remain an absent class member.
While Rigrodsky & Long, P.A. did not file the Complaint in
this matter, the firm, with offices in Wilmington, Delaware and
Garden City, New York, regularly litigates securities class,
derivative and direct actions, shareholder rights litigation and
corporate governance litigation, including claims for breach of
fiduciary duty and proxy violations in the Delaware Court of
Chancery and in state and federal courts throughout the United
States.
Attorney advertising. Prior results do not guarantee a similar
outcome.
Rigrodsky & Long, P.A.Timothy J. MacFall, EsquirePeter
Allocco888-969-4242516-683-3516Fax:
302-654-7530info@rl-legal.comhttp://www.rigrodskylong.com
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024